Proteome of the human heart mapped for the first time

November 15, 2017, Technical University Munich
Front: drawing of a cardiac muscle, background: excerpt from a so-called 'heatmap', an overview of the proteins analyzed for the proteomic map. Credit: Doll, Kraue, Menzfeld / MPIB

A healthy heart beats about two billion times during a lifetime, thanks to the interplay of more than 10,000 proteins. Researchers from the Max Planck Institute of Biochemistry (MPIB) and the German Heart Centre at the Technical University of Munich (TUM) have now determined which and how many individual proteins are present in each type of cell in the heart. They have now compiled the first atlas of the healthy human heart, known as the cardiac proteome. The atlas will make it easier to identify differences between healthy and diseased hearts in future.

Proteins are the molecular machines of , and they perform a range of functions. They are produced by the cells based on blueprints stored in their DNA. Changes occurring at the DNA or level can lead to disorders. For such changes to be recognized as underlying causes of disease, it is important to know precisely which proteins are present in the and in what quantities.

Protein map of the heart

The first such protein atlas of the heart was recently published in Nature Communications by a research team from Munich. The scientists determined the protein profile of cells in all the regions of the heart. In addition, they investigated the protein composition in three different cell types of the heart: cardiac fibroblasts, and endothelial cells. In this way, the researchers were able to map the distribution of proteins throughout the heart. Using mass spectrometry, they identified nearly 11,000 cardiac proteins.

Previous studies had focused for the most part only on individual cell types, or used tissue from diseased hearts. "This approach has two problems," says Sophia Doll of the MPIB and lead author of the study. "First, the results did not give a full picture of the heart across all its regions and tissues; and second, comparative data on healthy hearts were often missing. Our study has eliminated both problems. Now, the data can be used as a reference for future studies."

"Looking at the protein atlas of the human heart, you can see that all healthy hearts work in a very similar manner. We measured similar protein compositions in all the regions with few differences between them," she says. The researchers were also surprised to find that the right and left halves of the heart are similar, despite having quite different functions—the right half pumps oxygen-poor blood to the lungs, while the left half pumps oxygen-rich blood from the lungs to the body.

Sick vs healthy: identifying differences

In the next step, the team wanted to test whether the data from healthy hearts could serve as a control for detecting changes in diseased hearts. They compared their values with the cardiac proteomes of patients with atrial fibrillation, a very common rhythm disorder of the heart. Indeed, the results showed that the tissue of the diseased hearts was most different in proteins responsible for supplying energy to the cells.

The comparison provided yet another interesting finding: Although the proteins involved in energy metabolism were changed in all the patients, those changes differed between individuals. "These findings show us how important personalized medicine is. Although all the patients had very similar symptoms, we see from the data that a different molecular dysfunction was responsible in each case. We need to learn to recognize and treat such individual differences - especially in cardiac medicine," says adjunct teaching professor Dr. Markus Krane, deputy director of the Department of Cardiovascular Surgery of the German Heart Centre Munich at TUM.

Nearly 11,000 proteins in less than two days

Together with his colleagues at the Department of Cardiovascular Surgery, Krane has collected more than 150 tissue samples from over 60 cardiac operations and forensic samples. Using elaborate cell culture methods, they were able to extract the various . This large amount of cardiac material was a crucial factor for studying the individual heart regions so precisely. Professor Matthias Mann, head of the Proteomics and Signal Transduction Group at the MPIB, and his team carried out extensive mass spectrometric measurements. Thanks to advances in mass spectrometry and sample processing, the researchers are lighting the way towards personalized medicine.

The team at MPIB attaches great importance to precise, repeatable and fast analytical methods. They have improved the measuring technique to the extent that an entire heart region can now be determined in less than two days, twice as fast as previously. This is crucial, especially for potential use on patients.

The data will soon be available in the public database MaxQB .

Explore further: Team finds that telomere length can have a direct correlation to heart failure in humans

More information: Sophia Doll et al, Region and cell-type resolved quantitative proteomic map of the human heart, Nature Communications (2017). DOI: 10.1038/s41467-017-01747-2

Related Stories

Team finds that telomere length can have a direct correlation to heart failure in humans

September 7, 2017
Each cell in the average human body contains 23 pairs of chromosomes, with four telomeres on each pair. Telomeres cover the end of the chromosome, protecting it from deterioration or fusion with adjacent chromosomes, much ...

Study identifies key player in heart enlargement

June 27, 2017
The heart is a dynamic muscle that grows and shrinks in response to stressors such as exercise and disease. The secret to its malleability lies in individual cells, which get bigger or smaller depending on the heart's needs. ...

Id genes play surprise role in cardiac development

August 22, 2017
Researchers from Sanford Burnham Prebys Medical Discovery Institute (SBP), the Cardiovascular Institute at Stanford University and other institutions were surprised to discover that the four genes in the Id family play a ...

Cardiac stem cells from heart disease patients may be harmful

June 15, 2017
Patients with severe and end-stage heart failure have few treatment options available to them apart from transplants and "miraculous" stem cell therapy. But a new Tel Aviv University study finds that stem cell therapy may, ...

Heart signaling map sheds light on the molecular culprits behind cardiovascular disease

October 10, 2016
Having a big heart is not always a virtue and, from a physiologist's point of view, it can be deadly. An enlarged heart is a hallmark of dilated cardiomyopathy (DCM) and, despite being the most common inherited disease of ...

Recommended for you

Daily egg consumption may reduce cardiovascular disease

May 21, 2018
People who consume an egg a day could significantly reduce their risk of cardiovascular diseases compared with eating no eggs, suggests a study carried out in China, published in the journal Heart.

Natural antioxidant bilirubin may improve cardiovascular health

May 18, 2018
Bilirubin, a yellow-orange pigment, is formed after the breakdown of red blood cells and is eliminated by the liver. It's not only a sign of a bruise, it may provide cardiovascular benefits, according to a large-scale epidemiology ...

New algorithm more accurately predicts life expectancy after heart failure

May 17, 2018
A new algorithm developed by UCLA researchers more accurately predicts which people will survive heart failure, and for how long, whether or not they receive a heart transplant. The algorithm would allow doctors to make more ...

New genes found that determine how the heart responds to exercise

May 17, 2018
A new study by researchers at Queen Mary University of London and University College London (UCL) has discovered 30 new gene locations that determine how the heart responds to and recovers from exercise.

Novel therapy inhibits complement to preserve neurons and reduce inflammation after stroke

May 16, 2018
A team of investigators at the Medical University of South Carolina (MUSC) has developed a novel therapy for ischemic (clot-caused) stroke and has shown in a preclinical model that it locally inhibits complement at and around ...

Greater burden of atrial fibrillation linked to higher stroke risk

May 16, 2018
Among people with intermittently recurring atrial fibrillation who are not taking anti-blood-clotting medications, those whose hearts were in abnormal rhythms longer were three times more likely to have strokes or other types ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.